Literature DB >> 21326995

Plasma homocysteine as a risk factor for strokes in ghanaian adults.

Ak Akpalu1, Pk Nyame.   

Abstract

BACKGROUND: Stroke is an increasing problem in Ghana and the West African sub-region. New and modifiable risk factors for stroke have gained prominence in the last decade but have not been adequately researched in West Africa.
METHOD: This was a case-control study with plasma Homocysteine (Hcy) as an independent risk factor for stroke. 80 consecutive stroke patients with 80 age-sex matched controls were venesected in the fasting state for assay of Hcy and other biochemical parameters.
RESULTS: Mean Hcy level in stroke cases of 40.7 ± 9.5µmol/l was significantly higher than 16.8 ± 10.6µmol/l in controls [p<0.0001]. There was a significant association of hyperHcy with stroke [χ(2); p<0.0001]. OR of stroke calculated for quartiles of Hcy, demonstrated an increase in OR of 1.37 (25(th) percentile) to an OR of 3.80 (75(th) percentile).
CONCLUSIONS: Hcy was elevated in patients with stroke and should be considered as a modifiable risk factor for stroke in Ghanaian adults.

Entities:  

Keywords:  Ghana; Haemorrhage; Homocysteine; Hyperhomocysteinemia; Infarction; Stroke

Year:  2009        PMID: 21326995      PMCID: PMC2956365     

Source DB:  PubMed          Journal:  Ghana Med J        ISSN: 0016-9560


  39 in total

1.  What level of plasma homocyst(e)ine should be treated? Effects of vitamin therapy on progression of carotid atherosclerosis in patients with homocyst(e)ine levels above and below 14 micromol/L.

Authors:  D G Hackam; J C Peterson; J D Spence
Journal:  Am J Hypertens       Date:  2000-01       Impact factor: 2.689

2.  Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  Unhee Lim; Patricia A Cassano
Journal:  Am J Epidemiol       Date:  2002-12-15       Impact factor: 4.897

3.  Homocysteine and ischaemic stroke in men: the Caerphilly study.

Authors:  U B Fallon; P Elwood; Y Ben-Shlomo; J B Ubbink; R Greenwood; G D Smith
Journal:  J Epidemiol Community Health       Date:  2001-02       Impact factor: 3.710

4.  Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort.

Authors:  P F Jacques; A G Bostom; P W Wilson; S Rich; I H Rosenberg; J Selhub
Journal:  Am J Clin Nutr       Date:  2001-03       Impact factor: 7.045

5.  Homocysteine and risk of recurrent stroke.

Authors:  Gudrun Boysen; Thomas Brander; Hanne Christensen; Rolf Gideon; Thomas Truelsen
Journal:  Stroke       Date:  2003-04-17       Impact factor: 7.914

6.  Distribution and correlates of elevated total homocyst(e)ine: the Stroke Prevention in Young Women Study.

Authors:  W H Giles; S J Kittner; J B Croft; M A Wozniak; R J Wityk; B J Stern; M A Sloan; T R Price; R J McCarter; R F Macko; C J Johnson; B R Feeser; C J Earley; D W Buchholz; P D Stolley
Journal:  Ann Epidemiol       Date:  1999-07       Impact factor: 3.797

7.  Oxidative stress in the context of acute cerebrovascular stroke.

Authors:  M M El Kossi; M M Zakhary
Journal:  Stroke       Date:  2000-08       Impact factor: 7.914

Review 8.  Homocysteine and stroke.

Authors:  G J Hankey; J W Eikelboom
Journal:  Curr Opin Neurol       Date:  2001-02       Impact factor: 5.710

9.  Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects.

Authors:  Vijctor Sanchez-Margalet; Miguel Valle; Francisco J. Ruz; Felix Gascon; Joaquijn Mateo; Raimundo Goberna
Journal:  J Nutr Biochem       Date:  2002-02       Impact factor: 6.048

10.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

View more
  4 in total

Review 1.  The burden of stroke in Africa: a glance at the present and a glimpse into the future.

Authors:  Mayowa O Owolabi; Sally Akarolo-Anthony; Rufus Akinyemi; Donna Arnett; Mulugeta Gebregziabher; Carolyn Jenkins; Hemant Tiwari; Oyedunni Arulogun; Albert Akpalu; Fred Stephen Sarfo; Reginald Obiako; Lukman Owolabi; Kwamena Sagoe; Sylvia Melikam; Abiodun M Adeoye; Daniel Lackland; Bruce Ovbiagele
Journal:  Cardiovasc J Afr       Date:  2015 Mar-Apr       Impact factor: 1.167

2.  Hyperhomocysteinemia and folate levels in normal healthy Nigerians living in Zaria: Subanalysis of ABU homocysteine cross-sectional survey.

Authors:  Obiageli Uzoamaka Onyemelukwe; Bilkisu Bello Maiha
Journal:  Ann Afr Med       Date:  2019 Jul-Sep

3.  Risk factors and assessment for cardiovascular disease among HIV-positive patients attending a Nigerian tertiary hospital.

Authors:  Ifeyinwa Dorothy Osegbe; Oyetunji Olukayode Soriyan; Abiola Ann Ogbenna; Henry Chima Okpara; Elaine Chinyere Azinge
Journal:  Pan Afr Med J       Date:  2016-04-20

4.  Prevalence of hyperhomocysteinaemia, selected determinants and relation to hypertension severity in Northern-Nigerian hypertensives: the ABU homocysteine survey.

Authors:  Obiageli U Onyemelukwe; Bilkisu B Maiha
Journal:  Ghana Med J       Date:  2020-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.